As many as 40 000 pharmacies will soon have supplies of Paxlovid while the administration ramps up communications to clinicians and patients on access and use.
In response to reports that patients have had difficulty gaining access to the Pfizer COVID-19 antiviral treatment Paxlovid, the Biden administration on Tuesday announced steps to make the drug more widely available and to improve awareness of the oral treatment and its optimal use among both health care professionals and US citizens.
Paxlovid was shown in clinical trials to reduce the risk of COVID-19 hospitalization or death by approximately 90%. The US Food and Drug Administration authorized the pill in December 2021, but the rollout has been slow.
In the White House fact sheet released Tuesday, the administration announced it had purchased 20 million doses of the Pfizer drug and outlined the latest steps the government is taking to distribute medications for treating COVID and communicate more widely about their availability. These include: